CEACAM5 and pancreatic neoplasm: TIMP-1 was also included in a three-biomarker panel along with CA 19-9 and carcinoembryonic antigen (CEA), which provided a SN/SP of 76/90 for the classification of pancreatic cancer from benign pancreatic disease [8].